BioSpace News Archive

Drug development requires solid funding. Here’s who’s standing on higher ground this week with fresh investment dollars.

The company says it plans to file an IND for the candidate, dubbed CFT8919, by the middle of next year.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held at 10:00 a.m. at the Company’s headquarters chaired by Hedi Ben Brahim, Chairman and CEO, to approve the Company’s financial statements for the year ended December 31, 2020 and to vote the other resolutions submitted to their approval.

The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is pleased to announce the appointment of three new members to its Board of Directors.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Virtual Jaws & Paws Conference on Wednesday, June 2, 2021.

Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today that its application for Marketing Authorization (MA) for Endari® in the Kingdom of Saudi Arabia has been accepted by the Saudi Food and Drug Authority (SFDA)

Dr. Nagdev, Director of Emergency Ultrasound at Highland Hospital, has been a leading voice for point-of-care ultrasound use in emergency medicine

New analysis suggests the California variant is more transmissible than unmutated strains, but vaccines are effective against it

Tampa General Hospital is the first in the West Florida Region to provide new treatment for this common condition, which affects more than 15 million women in the U.S.